Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions
How We Work
Life at Takeda
Design Concept
Where we work
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Global Ethics & Compliance
From the CEO
Contact Us
Celebrating the grand opening of Takeda Global Headquarters
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Takeda Clinical Trial Transparency
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
T-CiRA
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
Find out Takeda's stories related on Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
An Empowered Women-led Workforce
Healthcare for All
Heritage
Keys to Aging Gracefully
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
SDGs
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
Takeda is committed to contributing to the long-term health of people through disease prevention.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
July 2018
July 18, 2018
7/18/2018
Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with Three New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)
July 18, 2018
7/18/2018
Takeda Submits an Application for a New Indication of Entyvio® (vedolizumab) for the Treatment of Adult Patients with Moderately to Severely Active Crohn’s Disease in Japan
July 13, 2018
7/13/2018
Termination of License and Development Agreement for "OBLEAN® Tablets 120mg" for Treatment of Obesity
July 11, 2018
7/11/2018
Phase 3 Trial of NINLARO® (ixazomib) as Maintenance Therapy Met Primary Endpoint Demonstrating Statistically Significant Improvement in Progression-Free Survival in Patients with Multiple Myeloma Post-Transplant
July 11, 2018
7/11/2018
Takeda Selected by the FTSE4Good Developed Index for the 14th Consecutive Year
July 10, 2018
7/10/2018
Takeda receives clearance from the United States Federal Trade Commission for the proposed acquisition of Shire plc
July 9, 2018
7/9/2018
Takeda Announces Selection of Three New Programs for Global Corporate Social Responsibility (CSR) Program 2018 Promoting Disease Prevention to Improve Health in Developing and Emerging Countries
July 6, 2018
7/6/2018
Takeda and TiGenix Announce Results of Second Acceptance Period
July 2, 2018
7/2/2018
Takeda Global Headquarters Grand Opening
1
2
3
4
5
TOP
